
Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO
2026-11-20 10:11:27Aurobindo Pharma Ltd. is currently rated 'Hold' by MarketsMOJO, a rating that was last updated on 25 May 2026. While this rating adjustment occurred several months ago, the analysis and financial metrics presented here reflect the stock's current position as of 20 November 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Read More
Aurobindo Pharma Sees Significant Open Interest Surge Amid Mixed Market Signals
2026-11-19 15:00:08Aurobindo Pharma Ltd. has witnessed a notable 10.57% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal decline in the stock price and subdued volume, the surge in open interest suggests that traders are recalibrating their directional bets amid a complex market backdrop.
Read More
Aurobindo Pharma Sees Sharp Open Interest Surge Amidst Narrow Price Range
2026-11-18 15:00:09Aurobindo Pharma Ltd. has witnessed a notable 13.9% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading close to its 52-week high, the stock’s mixed volume and delivery trends suggest cautious optimism among traders navigating the pharmaceuticals sector.
Read More
Aurobindo Pharma Sees Significant Open Interest Surge Amid Derivatives Activity
2026-11-18 14:00:09Aurobindo Pharma Ltd. has witnessed a notable 13.46% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.53% gain in the stock price, the pharmaceutical mid-cap’s recent trading patterns and volume dynamics suggest a complex interplay of bullish and cautious sentiment among traders.
Read More
Aurobindo Pharma Sees Sharp Open Interest Surge Signalling Renewed Market Interest
2026-11-18 13:00:08Aurobindo Pharma Ltd. has witnessed a notable surge in open interest in its derivatives segment, signalling increased market activity and evolving investor positioning. Despite a modest price gain and narrowing trading range, the pharmaceutical mid-cap’s recent volume and open interest dynamics suggest a complex interplay of bullish and cautious bets among traders.
Read More
Aurobindo Pharma Sees Significant Open Interest Surge Amid Narrow Price Movement
2026-11-17 15:00:06Aurobindo Pharma Ltd. has witnessed a notable 10.3% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite trading close to its 52-week high, the stock’s mixed volume patterns and falling investor participation suggest a complex outlook for this mid-cap pharmaceutical player.
Read More
Aurobindo Pharma Ltd. is Rated Hold by MarketsMOJO
2026-11-09 10:10:56Aurobindo Pharma Ltd. is rated 'Hold' by MarketsMOJO, with this rating last updated on 25 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 November 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Broad-Based Technical Strength Lifts Aurobindo Pharma Ltd. to 52-Week High of Rs 1819.3
2026-11-09 09:40:10Surging past Rs 1819.3 on 09 Nov 2026, Aurobindo Pharma Ltd. has marked a significant milestone by reaching a fresh 52-week high, propelled by a sustained 12-day rally that has delivered a 15.43% gain. This performance notably outpaces the broader Sensex, which slipped 0.18% on the same day, underscoring the stock's robust momentum within the Pharmaceuticals & Biotechnology sector.
Read MoreAurobindo Pharma Gains 7.10%: 6 Key Factors Driving the Week’s Momentum
2026-11-08 15:00:40Key Events This Week Nov 2: Technical momentum shifts signal bullish outlook Nov 5: New 52-week high at Rs.1,748.85 and intraday peak of Rs.1,785.5 Nov 5: Strong quarterly growth upgrades financial trend to positive Nov 6: New 52-week high at Rs.1,805 despite slight daily dip Week OpenRs.1,677.80 Week Close<div class=...
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
19-Nov-2026 | Source : BSESubmission of copy of notice published in newspapers.
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
18-Nov-2026 | Source : BSESubmission of Postal Ballot Notice.
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
11-Nov-2026 | Source : BSESubmission of Earning Call Transcript for Q2FY27.
Corporate Actions
No Upcoming Board Meetings
Aurobindo Pharma Ltd. has declared 700% dividend, ex-date: 11 Nov 26
Aurobindo Pharma Ltd. has announced 1:5 stock split, ex-date: 10 Feb 11
Aurobindo Pharma Ltd. has announced 1:1 bonus issue, ex-date: 20 Jul 15
No Rights history available